Literature DB >> 20864982

Disclose all data in publications.

Keith Baggerly.   

Abstract

Mesh:

Year:  2010        PMID: 20864982     DOI: 10.1038/467401b

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  Repeatability of published microarray gene expression analyses.

Authors:  John P A Ioannidis; David B Allison; Catherine A Ball; Issa Coulibaly; Xiangqin Cui; Aedín C Culhane; Mario Falchi; Cesare Furlanello; Laurence Game; Giuseppe Jurman; Jon Mangion; Tapan Mehta; Michael Nitzberg; Grier P Page; Enrico Petretto; Vera van Noort
Journal:  Nat Genet       Date:  2008-01-28       Impact factor: 38.330

  1 in total
  21 in total

1.  Improving validation practices in "omics" research.

Authors:  John P A Ioannidis; Muin J Khoury
Journal:  Science       Date:  2011-12-02       Impact factor: 47.728

2.  BioQ: tracing experimental origins in public genomic databases using a novel data provenance model.

Authors:  Scott F Saccone; Jiaxi Quan; Peter L Jones
Journal:  Bioinformatics       Date:  2012-03-16       Impact factor: 6.937

3.  More time for research: fund people not projects.

Authors:  John P A Ioannidis
Journal:  Nature       Date:  2011-09-28       Impact factor: 49.962

Review 4.  Lessons learned from radiation oncology clinical trials.

Authors:  Fei-Fei Liu; Paul Okunieff; Eric J Bernhard; Helen B Stone; Stephen Yoo; C Norman Coleman; Bhadrasain Vikram; Martin Brown; John Buatti; Chandan Guha
Journal:  Clin Cancer Res       Date:  2013-09-16       Impact factor: 12.531

5.  Call for Action: Journals Need to Insist on Full Reporting of the Analytical Characteristics of Biomarkers.

Authors:  Zhen Zhao; David B Sacks
Journal:  Lab Med       Date:  2021-01-04

Review 6.  Knowledge integration in cancer: current landscape and future prospects.

Authors:  John P A Ioannidis; Sheri D Schully; Tram Kim Lam; Muin J Khoury
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-23       Impact factor: 4.254

7.  Cancer in silico drug discovery: a systems biology tool for identifying candidate drugs to target specific molecular tumor subtypes.

Authors:  F Anthony San Lucas; Jerry Fowler; Kyle Chang; Scott Kopetz; Eduardo Vilar; Paul Scheet
Journal:  Mol Cancer Ther       Date:  2014-10-27       Impact factor: 6.261

8.  Clinical trials in the era of personalized oncology.

Authors:  Michael L Maitland; Richard L Schilsky
Journal:  CA Cancer J Clin       Date:  2011-10-27       Impact factor: 508.702

Review 9.  Proteomics and metabolomics in renal transplantation-quo vadis?

Authors:  Rahul Bohra; Jacek Klepacki; Jelena Klawitter; Jost Klawitter; Joshua M Thurman; Uwe Christians
Journal:  Transpl Int       Date:  2012-11-21       Impact factor: 3.782

10.  Independent validation of a model using cell line chemosensitivity to predict response to therapy.

Authors:  Wenting Wang; Keith A Baggerly; Steen Knudsen; Jon Askaa; Wiktor Mazin; Kevin R Coombes
Journal:  J Natl Cancer Inst       Date:  2013-08-20       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.